期刊文献+

沙利度胺联合DVD方案治疗复发/难治型多发性骨髓瘤15例临床观察 被引量:2

原文传递
导出
摘要 多发性骨髓瘤(MM)是浆细胞克隆性增生的恶性血液肿瘤,虽然硼替佐米作为一种新型的生物靶向治疗药物在MM的治疗中取得了较好的疗效,特别是对复发/难治型MM,但仍有部分患者应用后复发或疗效不佳,成为晚期复发/难治型患者。我们应用沙利度胺联合脂质体阿霉素、长春地辛、地塞米松(T—DVD)方案治疗15例晚期复发/难治型MM,取得一定疗效,现报道如下。
出处 《中华内科杂志》 CAS CSCD 北大核心 2013年第12期1055-1056,共2页 Chinese Journal of Internal Medicine
  • 相关文献

参考文献8

  • 1Takamatsu Y, Sunami K, Muta T, et al. Bortezomib, doxorubicin and intermediate-dose dexamethasone (iPAD) therapy for relapsed or refractory multiple myeloma : a muhicenter phase 2 study, lnt J Hematol, 2013, 98 : 179-185.
  • 2Held LA, Rizzieri D, Long GD, et al. A Phase I study of arsenic trioxide ( Trisenox ), ascorbic acid, and bortezomib ( Velcade ) combination therapy in patients with relapsed/refractory multiple myeloma. Cancer Invest, 2013, 31:172-176.
  • 3Durie BG, Harousseau JL, Miguel JS, et al. International uniform response criteria for multiple myeloma. Leukemia, 2006, 20: 1467-1473.
  • 4Duggan ST, Keating GM. Pegylated liposomal doxorubicin: a review of its use in metastatic breast cancer, ovarian cancer, multiple myeloma and AIDS-related Kaposi's sarcoma. Drugs, 2011, 71:2531-2558.
  • 5Hussein MA, Baz R, Srkalovie G, et al. Phase 2 study of pegylated liposomal doxorubicin, vincristine, decreased-frequency dexamethasone, and thalidomide in newly diagnosed and relapsed- refractory multiple myeloma. Mayo Clin Proc, 2006, 81:889- 895.
  • 6Offidani M, Corvatta L, Polloni C, et al. Thalidomide, dexamethasone, Doxil and Velcade (ThaDD-V) followed by consolidation/maintenance therapy in patients with relapsed- refractory multiple myeloma. Ann Hematol, 2011, 90: 1449- 1456.
  • 7Auel B, Goldschmidt H, Geer T, et al. Treatment with Thalidomide and Cyclophosphamide (TCID) is Superior to Vincristine ( VID ) and to Vinorelbine ( VRID ) Regimens in Patients with Refractory or Recurrent Multiple Myeloma. Indian J Hematol Blood Transfus, 2012, 28:67-76.
  • 8Zervas K, Mihou D, Katodritou E, et al. VAD-doxil versus VAD- doxil plus thalidomide as initial treatment for multiple myeloma: results of a muhicenter randomized trial of the Greek Myeloma Study Group. Ann Oncoi, 2007, 18 : 1369-1375.

同被引文献12

引证文献2

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部